XNAS · CRIS
-1.57% · -$0.0100 · Vol 334.3K
Live · updated 11:59:57 ET
Curis Inc

Curis Inc

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
$0.7250
Card
Relationship Map

Follow $CRIS

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CRIS by email

Veridion Score

BETALOW CONF · 6 of 6 factors measuredMethodology
CRIS
Curis Inc
Wed Oct 7 · last completed session · daily score · 18h old
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

43/ 100
Veridion Score
Lower range · LOW confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6 of 6 factors measured · Wed Oct 7 · last completed session · daily score · 18h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CRIS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CRIS catalysts
About Curis Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2000
Employees
24
Country
US

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.7145
Day high
$0.8199
Day low
$0.6130
Previous close
$0.7366
52W high
$32.60
-97.78% from high
52W low
$0.6130
0% of range
Market cap
$1.8M
Beta
1.63
Shares out
2.4M
Volume
334.3K
2.08× rel vol
Avg volume
160.4K
VWAP
$0.7069
Price history computed in-house
1W
-12.72%
1M
-42.91%
3M
-85.38%
1Y
-97.76%
YTD
-96.33%
SMA 50 $1.87 · below
SMA 200 $10.65 · below
52W position 0%

CRIS overview

Veridion Score
43
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CRIS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CRIS Form 4 filings
Public disclosures

Congress activity in CRIS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

CRIS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CRIS in this window.
Lobbying spend

CRIS lobbying filings, year to date.

Registered lobbying filings matched to Curis Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CRIS in this window.
Loading news for CRIS
Analyst ratings
Sovereign unlock shows live analyst consensus for CRIS.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.